675 results on '"Ito, Yasuki"'
Search Results
2. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
3. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
4. Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy
5. Displacement of the retina and changes in the foveal avascular zone area after internal limiting membrane peeling for epiretinal membrane
6. Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
7. Clinical findings in eyes with BEST1-related retinopathy complicated by choroidal neovascularization
8. Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
9. Macular morphology after macular hole surgery using the inverted internal limiting membrane flap technique
10. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
11. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
12. SPONTANEOUS CLOSURE OF MACULAR HOLE AFTER VITRECTOMY FOR MYOPIC RETINOSCHISIS WITH FOVEAL DETACHMENT
13. Seasonal variation in submacular hemorrhages in retinal macroaneurysms and its disappearance in age-related macular degeneration
14. Long-term Morphological Changes in Macular Neovascularization under Aflibercept Treatment with a Treat-and-Extend Regimen
15. Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy
16. Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease.
17. TENAYA and LUCERNE
18. Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration
19. Faricimab Treat-and-Extend for Diabetic Macular Edema
20. Prevalence of and factors associated with dilated choroidal vessels beneath the retinal pigment epithelium among the Japanese
21. Clinical characteristics and high resolution retinal imaging of retinitis pigmentosa caused by RP1 gene variants
22. Changes in intraocular pressure and aqueous flare in eyes with multiple evanescent white dot syndrome
23. Analysis of macular curvature in normal eyes using swept-source optical coherence tomography
24. Spontaneous closure of macular hole after vitrectomy for myopic retinoschisis with foveal detachment
25. Number of Hyperreflective Foci in the Outer Retina Correlates with Inflammation and Photoreceptor Degeneration in Retinitis Pigmentosa
26. Intra- and Postoperative Monitoring of Autologous Neurosensory Retinal Flap Transplantation for Refractory Macular Hole Associated with High Myopia
27. Three cases of acute-onset bilateral photophobia
28. Consumption of Fructose and High Fructose Corn Syrup Increase Postprandial Triglycerides, LDL-Cholesterol, and Apolipoprotein-B in Young Men and Women
29. Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
30. A Case of Autism Spectrum Disorder with Perforated Keratomalacia due to Vitamin A Deficiency
31. DIAGNOSTIC CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY BASED ON B-SCAN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND ITS INTERRATER AGREEMENT COMPARED WITH INDOCYANINE GREEN ANGIOGRAPHY
32. Different inverse association of large high-density lipoprotein subclasses with exacerbation of insulin resistance and incidence of type 2 diabetes: The Nagahama study
33. The causal effects of alcohol on lipoprotein subfraction and triglyceride levels using a Mendelian randomization analysis: The Nagahama study
34. Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration
35. Cerebral Venous Sinus Thrombosis with Bilateral Optic Disc Swelling and Bilateral Sixth Nerve Palsies in the Absence of Headache: A Case Report.
36. CHANGES OF CONE PHOTORECEPTOR MOSAIC IN AUTOSOMAL RECESSIVE BESTROPHINOPATHY
37. CHARACTERISTICS AND CLASSIFICATION OF TYPE 3 NEOVASCULARIZATION WITH B-SCAN FLOW OVERLAY AND EN FACE FLOW IMAGES OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
38. INNER MACULAR CHANGES AFTER VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR RHEGMATOGENOUS RETINAL DETACHMENT: Similarity With Alport Syndrome
39. Assessment of factors affecting flicker ERGs recorded with RETeval from data obtained from health checkup screening
40. Relationship between tinnitus and olfactory dysfunction: audiovisual, olfactory, and medical examinations
41. Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database
42. The influence of triglycerides on small dense low‐density lipoprotein cholesterol levels is attenuated in low low‐density lipoprotein‐cholesterol range: Implications for the negative results of the PROMINENT trial
43. LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN
44. Multimodal Imaging in Bilateral Nature of the Choroidal Osteoma After Intraocular Inflammation Caused by Harada Disease
45. Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes
46. Small Dense Low-Density Lipoprotein Cholesterol Levels in Breakfast Skippers and Staple Foods Skippers
47. EFFECTS OF HALF-DOSE PHOTODYNAMIC THERAPY ON CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH OR WITHOUT MACULAR NEOVASCULARIZATION ASSESSED USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
48. Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
49. Differences in ocular findings in two siblings: one with complete and other with incomplete achromatopsia
50. Short-term focal macular electroretinogram of eyes treated by aflibercept & photodynamic therapy for polypoidal choroidal vasculopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.